SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-152673
Filing Date
2010-07-01
Accepted
2010-07-01 16:07:35
Documents
5
Period of Report
2010-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20784
2 SEPARATION OF EMPLOYMENT AND CONSULTING AGREEMENT dex101.htm EX-10.1 50717
3 PRESS RELEASE dex991.htm EX-99.1 14083
4 GRAPHIC g34179ex99_1pg01a.jpg GRAPHIC 17934
5 GRAPHIC g34179ex99_1pg01b.jpg GRAPHIC 3421
  Complete submission text file 0001193125-10-152673.txt   116852
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31577 | Film No.: 10931035
SIC: 2834 Pharmaceutical Preparations